1 / 35

Ch 29 Fluid Management & transfusion

Ch 29 Fluid Management & transfusion. 성 준 경. A. Evaluation of intravascular volume. 1. Physical examination Most reliable preoperatively Hypovolemia Invaluable clues. A. Evaluation of intravascular volume. Hypervolemia Pitting edema Presacral(bedridden), pretibial(ambulatory pt.)

samantha-horton
Download Presentation

Ch 29 Fluid Management & transfusion

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Ch 29Fluid Management & transfusion 성 준 경

  2. A. Evaluation of intravascular volume 1. Physical examination • Most reliable preoperatively • Hypovolemia • Invaluable clues

  3. A. Evaluation of intravascular volume • Hypervolemia • Pitting edema • Presacral(bedridden), pretibial(ambulatory pt.) • Increased urinary flow • Late sings • tachycardia • pulmonary crackles • wheezing • cyanosis • pink & frothy pulmonary secretion

  4. A. Evaluation of intravascular volume 2. Laboratory evaluation • Serial Hct. • Arterial blood pH • Urinary specific gravity or osmolality • Urinary sodium or chloride conc. • Serum sodium • Serum BUN/Cr ratio

  5. A. Evaluation of intravascular volume • Lab signs of dehydration • Rising Hct. • Progressive metabolic acidosis • Urinary specific gravity > 1.010 • Urinary osmoloality > 450 mOsm/kg • Urinary sodium < 10 mEq/L • Hypernatremia • BUN:Cr ratio > 10:1 • Singns of volume overload • Radiologic sign • Increased pulmonary vascular and interstitial markings(Kerly B sign) • Diffuse alveolar infiltrate

  6. A. Evaluation of intravascular volume 3. Hemodynamic measurement • CVP • low values(<5 mmHg) • Hypovolemia의 다른 sing이 없다면 는 보통 정상 • Response to a fluid bolus(250 mL) • Small elevation(1-2)  need for more fluid • Large increase(>5)  slow rate administration & re-evaluation of volume status • 12 mmHg이상  hypervolemia • Pulmonary a. pr. • PAOP < 8 mmHg : hypovolemia • PAOP > 18 mmHg : left ventricular volume overload • Newer techniques • Transesophageal echocardiography • Radioisotopes  more accurate but not as widely available

  7. B. Intravenous fluid • Crystalloid solution • Low-molecular-weight ions(salt) with or without glucose • Colloid solutions • High-molecular-weight substances (Protein, large glucose polymers) < General facts > • Crystalloid is effective ascolloid with sufficient volume • Colloid 에 비해 3~4배의 양이 필요 • Colloid를 사용해 혈관내액을 보충하게 되면 더 빠른 교정이 가능 • 4~5L이상의 crystalloid 투여는 tissue edema를 더 쉽게 유발 < Severe tissue edema > • 산소운반을 방해 • 조직회복을 더디게 함 • bowel function이 돌아오는데 더 많은 시간 필요

  8. B. Intravenous fluid1. Crystalloid solution • Initial resucitation fluid • 3~4 L 의 crystalloid로 hemodynamic reponse가 충분치 않으면 colloid added • Mainly freewater loss  hypotonic solution replacement (=maintenance-type solution) • Both water and electrolyte loss  isotonic electrolyte solution (=called replacement-type solutions)

  9. B. Intravenous fluid1. Crystalloid solution • Lactated Ringer’s solution • m/c used fluid • Slightly hypotonic (sodium : 130 mEq/L) • Large volume이 필요한 경우 가장 physiologic solution • Lactate : liver에서 bicarbonate로 convert • Normal saline • Dilutional hyperchloremic acidosis (Choride 농도 증가  Bicarbonate농도 감소) • Hypochloremic alkalosis시 preferrable • Diluting packed RBC during transfusion • 5DW : pure water deficit , Na restriction • Hypertonic 3% saline : severe symptomatic hyponatremia시 • 3 ~ 7.5% saline : hypovolemic shock pt.

  10. B. Intravenous fluid1. Crystalloid solution • (표 2)

  11. B. Intravenous fluid2. Colloid solution • Intravascular half-lives  3~6 시간 • Crystalloid  20~30분 • Indication • Severe intravascular fluid deficit patients (eg.hemorrhagic shock)의 fluid resuscitation시 transfusion을 위한 blood도착 전에 • Severe hypoalbuminemia • Burn가 같은 large protein loss시 -Many clinician들이 transfusion 전에 3-4L의 fluid replacement가 필요한 경우 crystalloid와 함께 사용함

  12. B. Intravenous fluid2. Colloid solution • Blood derived colloid : Albumin, plasma protein fraction • 적어도 10시간 이상 60도 이상으로 가열하여야 hepatitis나 다른 virally transmitted disease를 최소화할 수 있음 • Plasma protein fraction • Hypotensive reaction • Allergic in nature

  13. B. Intravenous fluid2. Colloid solution • Synthetic colloid : dextran, gelatins, Hetastarch, pentastarch • Gelatin은 histamine-mediated allergic reaction으로 미국에선 사용되지 않음 • Dextran 40, dextran 70 • Improves blood flow through microcirculation – lowers blood viscosity • 20 mL/kg이상 주입시 blood typing을 방해할 수 있으며, bleedign time연장시킬 수 있음. • Antigenic하기 때문에 dextran 1을 먼저 투여하여 anaphylactic reaction예방 • Hetastarch (Hydoxyethyl starch)  Voluven • Plasma expander로 highly effective하지만 albumin보다 less expensive • Nonantigenic하며 anaphylactoid reaction이 rare • 0.5~1 L주입시에는 Coagulation study, bleeding time에 별 영향 없음 • Pentastarch  Pentaspan • Lower molecular weight • Adverse effect가 적어 hetastarch 대체 가능

  14. C. Perioperative fluid therapy • Normal maintenance requirement • Preexisting fluid deficits • Surgical wound losses

  15. C. Perioperative fluid therapy 1. Normal maintenance requirements • Urine formation • GI secretion • Sweating • Insensible loss from skin and lung

  16. C. Perioperative fluid therapy2. Preexisting deficit • ( Normal maintenance rate x length of the fast ) • In reality, this deficit will be somewhat less as a result of renal conversion • Abnormal fluid losses • Bleeding, vomiting, diuresis, diarrhea • Occult losses (redistribution) • Traumatized tissue • Infected tissue • Ascites • Fever, sweating, hyperventilation  Can be overlooked

  17. C. Perioperative fluid therapy3. Surgical fluid loss a. Blood loss (1) Surgical suction container (2) Visually estimating blood on - surgical sponge  4*4 : 10 mL - laparotomy pad  100-150 mL (3) Hct. : long procedure나 estimation이 어려울 때 유용 b. Other fluid loss (1) Evaporation (2) Internal redistribution of body fluid(=third spacing) - traumatized, inflamed, infected tissue - cellular dysfunction - loss of lymphatic fluid

  18. C. Perioperative fluid therapy 4. Intraoperative fluid replacement • Maintenance + preexisting dehydration + intraop loss • Minimal bleeding & water loss  maintenance solution • 그 외 모든 수술  lactated Ringer’s solution a. Replacing blood loss • Anemia danger가 transfusion risk를 넘어서기 전까지는 crystalloid나 colloid로 replace하는 것이 좋음. • 보통 hemoglobin 7~8 g/dL(Hct. 21~24%) • Elderly, significant cardiac or pul. dis.  10 g/dL • Transfusion 전까지 blood loss의 • Lactated Ringer’s solution은 3-4배 • Colloid 는 1:1 ratio 로 given

  19. C. Perioperative fluid therapy 4. Intraoperative fluid replacement Determining transfusion point Allowable blood loss 1. Estimate blood volume 2. preopRBC volume estimation 3. Hematocrit 30%에서의 RBCV estimation 4. preopRBCV – 30% RBCV 5. (4.)x3 Other guidelines • RBC 1 unit  increase Hb. 1 g/dL(Hct 2-3%) • RBC 10 mL/kg  increase Hb 3 g/dL(Hct 10%) Ex) 85kg 술전 Hct 35% 총혈액량 85 x 65 = 55225 RBC vol 35% = 5525 x 35% = 1934 RBC vol 30% = 5525 x 30% = 1658 RBC loss at 30% = 276 Allowable blood loss 276 x 3 = 828

  20. C. Perioperative fluid therapy 4. Intraoperative fluid replacement b. Replacing redistribution & evaporative losses

  21. D. TransfusionCompatibility testing • ABO-Rh testing • Crossmatching • Confirm ABO and Rh typing • Other blood group system의 Ab. detect • 쉽게 agglutinate하지않거나 low titer Ab. detect • Antibody screen • Non-ABO hemolytic reaction을 일으키는 흔한 Ab.의 detection • Indirect Coombs test • Emergency transfusion  type O Rh-negative

  22. D. TransfusionBlood bank practice • CPDA-1 : m/c used preservative-anticoagulant solution • Citrate : anticoagulant(by binding calcium) • Phosphate : buffer • Dextrose : red cell energy source • Adenosine : ATP synthesis의 precursor • 1 unit of blood • 250 ml of PRBC : 1~6 °C에 보관 • Platelet and plasma : 20~24 °C에 5일동안 보관 • Fresh frozen plasma : 200mL, high conc. of factor VIII and fibrinogen

  23. D. Transfusion Intraoperative transfusion practice • Packed RBC • Ideal for patient requiring red cells not volume replacement • Volume replacement를 위해 second line을 통해 crystalloid를 주입 • Transfusion전 blood bank slip과 recipient’s identitybracelet확인 • Transfusion tubing은 clot, debris를 거르기 위한 170-um filter를 가지고 있어야 함 • 37 °C로 가온하여 주입 • Blood warmer : 150 mL/min에서까지 30 °C이상으로 유지할 수 있어야 함 • Warming failure  hypothermia • Stored RBBC 의 low 2,3-DPG conc. • Hb-Oxygen curve의 Lt shift • Tissue hypoxia

  24. D. Transfusion Intraoperative transfusion practice • Fresh frozen plasma • Contains all plasma protein(all clotting factor포함) • Indication • Treatment of isolated factor deficiencies • Reversal of warfarin therapy • Correction of coagulopathy associated with liver disease • 1 unit 는 각각의 clotting factor를 2~3% 증가시킴. • Initial therapeutic dose : 10-15 ml/kg • Goal : normal coagulation factor conc.의 30%도달. • Also used • Massive blood transfusion • Continue to bleed following platelet transfusion • Anti thrombin III deficiency • Thrombotic thrombocytopenic purpura

  25. D. Transfusion Intraoperative transfusion practice • Platelet • Bleeding이 있으며 thrombocytopenia or dysfunctional platelet 환자에서 투여 • Prophylactic platelet transfusion • 10,000 – 20,000 * 109 /L 이하시 • 50,000 * 109 /L 이하시 surgery중 blood loss 증가함. • Thrombocytopenic patient  op전 100,000 * 109 /L 까지 증가시켜야 • 1 unit  10,000 -20,000 * 109 /L 증가시킴. • Granulocyte transfusion • In neutropenic patient with bacterial infections not responding to antibiotics • Irradiation으로 transfusion 부작용 줄일 수 • G-CSF, GM-CSF사용으로 granulocyte transfusion은 줄어들었음.

  26. E. Complication of blood transfusionImmune Cx: Hemolytic Reaction 1.Hemolytic reaction - 보통 recipient’s Ab.에 의해 transfused red cell의 specific destruction과 연관됨. Acute : intravascular Delayed : extravascular

  27. E. Complication of blood transfusionImmune Cx: Hemolytic Reaction • Acute hemolytic reaction • 보통 ABO blood incompatibility에 의함 • Frequency ; 1:38,000 transfusion • M/c cause : misidentification • Symptom • In awake : chill, fever, nausea, chest &flank pain • In anesthetized : rise in temperature, unexplained tachycardia, hypotension, hemoglobinuria, diffuse oozing in the surgical field •  DIC, shock, renal shutdown으로 빠르게 진행될 수 있음 • Severity는 주입된 blood 양과 관계 있으며 10-15 mL만 들어가도 severe Sx.을 일으킬 수 있음.

  28. E. Complication of blood transfusionImmune Cx: Hemolytic Reaction • Management of hemolytic reaction • Hemolytic reaction이 의심되면 transfusion을 즉시 중지 • Blood slip과 patient’s identity bracelet을 recheck • Identifying Hb. in plasma, repeat compatibility testing, coagulation studies and platelet count을 위한 blood 채취. • Urinary catheter삽입하여 urine의 Hb. Check • Mannitol과 IV fluid로 osmotic diuresis • Rapid blood loss시 platelet, FFP투여

  29. E. Complication of blood transfusionImmune Cx: Hemolytic Reaction 2. Delayed hemolytic reactions • Extravascular hemolysis, 보통 mild함. • Caused by • Non-D antigens of Rh system • Other system : Kell, Duffy, Kidd antigens • Ab.가 형성될 chance : 1-1.6% • Reexposure시 anamnestic Ab. Reaction을 trigger : Kidd Ag. System에서 잘 발생 • Symptom • Malaise, jaundice, fever • Diagnosis : direct Coombs test • Tx. : supportive • Frequency : 1:12,000 transfusion

  30. E. Complication of blood transfusionImmune Cx: Nonhemolytic Reaction • Due to sensitization to donor’s white cell, platelet, plasma protein • Febrile reaction • White cell or platelet에 의함 • 1-3% of transfusion • Tx. : White cell-poor RBC 사용 • Urticarial reaction • Plasma protein에 의함 • 1% of transfusion • Tx. : antihistamine and steroid • Anaphylactic reaction • Rare : 1 in 150,000 transfusion • 주로 IgA-deficienct patients with anti-IgA Ab.가 IgA-containing blood를 transfusion받았을 때 생김. • Tx. : epinephrine, fluids, corticosteroid, H1 and H2 blocker

  31. E. Complication of blood transfusionImmune Cx: Nonhemolytic Reaction • Noncardiogenic pulmonary edema • TRALI : transfusion-related acute lung injury • < 1:10,000 • Initial Tx.는 ARDS와 비슷 • Graft-versus-Host disease • Immune-compromised patient에서 보임 • Blood product의 Lymphocyte에 의해 • Filter와 irradiation으로 lymphocyte를 inactivate • Posttransfusion purpura • Due to platelet alloantibody • Tx. : plasmapheresis • Immune suppression • Leukocyte-containing blood product시 immunosuppressive함: renal transplant recipients가 preop. transfusion시 graft survival이 향상됨. • Blood transfusion은 surgery, trauma후 serious infection incidence가 증가

  32. E. Complication of blood transfusionInfectious complication • Viral infection • Hepatitis • AIDS • CMV • Parasitic infection • Malaria, toxoplasmosis, Chagas’ disease • Very rare • Bacterial infection • 2nd leading cause of transfusion-associated death • Prevalence • Platelet product  1/2000 ,pRBC  1/250,000 • Contamination피하기 위해 4시간 안에 주입되어야 함.

  33. E. Complication of blood transfusionMassive transfusion • Patient blood volume의 1-2배 수혈시를 말함 (대부분 성인의 경우 10-20unit에 해당) • Complication • Coagulopathy • M/c cause : dilutional thrombocytopenia • Platelet, FFP • Citrate toxicity • Hypocalcemia, cardiac depression (rare) • Hepatic disease pt.는 calcium infusion고려

  34. E. Complication of blood transfusionMassive transfusion • Complication • Hypothermia • 30°C에 가까워지면 ventricular arrhythmia에서 fibrillation으로 진행이 자주 발생 • Acid-base balance • Acidosis: uncommon • M/c abnormality : postoperative metabolic alkalosis(citrate and lactate가 liver에서 bicarbonate로 converted) • Serum potassium conc. • Stored blood는 시간이 지남에 따라 K+증가 • Hyperkalemia: rate > 100mL/min • Hypokalemia는 postop metabolic alkalosis와 관련

  35. F. Alternative strategies for management of blood loss during surgery • Autologous transfusion • 보통 수술 4-5주전 시행 • Hct 최소 34%이상, Hb 11 g/dL이상 되어야 함 • Plasma volume이 normal로 돌아오는데는 최소 72시간이 걸림 • Blood salvage & reinfusion • Contraindication : septic contamination of wound, malignant tumor • Normovolemic hemodilution • 술전 blood를 빼놓고 crystalloid와 colloid로 보충해준 다음 술후에 stored blood를 given back

More Related